Related Experiment Video

Updated: Jul 27, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

Hepatitis C virus genotyping: clinical implications and methods

F S Nolte1

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. fnolte@emopry.edu

Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|January 5, 2002
PubMed

Insights

Hepatitis C virus (HCV) causes chronic liver disease globally. Identifying HCV genotype through nucleotide sequencing is crucial for predicting treatment response and duration.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Hepatitis C virus (HCV) chronically infects over 1% of the global population, leading to end-stage liver disease.
  • HCV exhibits significant genomic diversity with six major genotypes and numerous subtypes, varying by geographic distribution.
  • Viral genomic plasticity and quasispecies evolution enable persistent HCV infections.

Purpose of the Study:

  • To highlight the importance of Hepatitis C virus (HCV) genotype in predicting antiviral therapy outcomes.
  • To emphasize the role of genomic diversity in HCV persistence and treatment response.
  • To underscore the significance of accurate HCV genotyping methods.

Main Methods:

  • Review of existing literature on HCV genotyping methods.
  • Analysis of the impact of HCV genotype on antiviral therapy.
  • Nucleotide sequencing of phylogenetically informative regions as the gold standard for HCV genotyping.

Main Results:

  • HCV genotype is a critical factor in predicting sustained virologic response to therapy.
  • Genotype influences the optimal duration of antiviral treatment for Hepatitis C.
  • Genomic diversity and quasispecies evolution contribute to treatment challenges.

Conclusions:

  • Accurate determination of Hepatitis C virus (HCV) genotype is essential for effective patient management.
  • Nucleotide sequencing provides the most reliable method for HCV genotyping.
  • Understanding HCV genomic diversity is key to improving treatment strategies and outcomes.

More Related Videos

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...